Dave Perrill
Insider
First SEC filing: March 31, 2026 · Latest: March 31, 2026
Insider at
Insider transactions
0 buys (P)
3 sells (S)
Net: $-1,364,750
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 19, 2026 | HIVE | S | 100,000 | $2.72 | $272,000 | 12,500 Direct | -88.89% | Disposed | 9.4% (price as of 2026-10-02) |
| Aug. 19, 2026 | HIVE | S | 100,000 | $2.72 | $272,000 | 0 Direct | -100.00% | Disposed | 9.4% (price as of 2026-10-02) |
| Aug. 18, 2026 | HIVE | M | 12,500 | · | · | 112,500 Direct | +12.50% | Acquired | (price as of 2026-10-02) |
| Aug. 18, 2026 | HIVE | M | 12,500 | · | · | 312,500 Direct | -3.85% | Disposed | (price as of 2026-10-02) |
| July 9, 2026 | HIVE | M | 100,000 | · | · | 325,000 Direct | -23.53% | Disposed | (price as of 2026-10-02) |
| July 9, 2026 | HIVE | M | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 30, 2026 | HIVE | M | 100,000 | · | · | 425,000 Direct | +30.77% | Acquired | (price as of 2026-10-02) |
| June 19, 2026 | HIVE | S | 175,000 | $4.69 | $820,750 | 0 Direct | -100.00% | Disposed | -36.6% (price as of 2026-10-02) |
| May 7, 2026 | HIVE | M | 12,500 | · | · | 325,000 Direct | -3.70% | Disposed | (price as of 2026-10-02) |
| May 7, 2026 | HIVE | M | 100,000 | · | · | 337,500 Direct | -22.86% | Disposed | (price as of 2026-10-02) |
| May 7, 2026 | HIVE | M | 12,500 | · | · | 175,000 Direct | +7.69% | Acquired | (price as of 2026-10-02) |
| May 7, 2026 | HIVE | M | 100,000 | · | · | 162,500 Direct | +160.00% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 18, 2026 | HIVE | Restricted Share Units | Common Stock | · | · | 12,500 | Disposed |
| July 9, 2026 | HIVE | Restricted Share Units | Common Stock | · | · | 100,000 | Disposed |
| June 30, 2026 | HIVE | Restricted Share Units | Common Stock | · | · | 100,000 | Acquired |
| May 7, 2026 | HIVE | Restricted stock units | Common Stock | · | · | 12,500 | Disposed |
| May 7, 2026 | HIVE | Restricted stock units | Common Stock | · | · | 100,000 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 31, 2026 | HIVE | Common Stock | 62,500 | Direct |
| March 31, 2026 | HIVE | Options (right to buy) | 20,000 | Direct |
| March 31, 2026 | HIVE | Restricted Stock Units | 37,500 | Direct |
| March 31, 2026 | HIVE | Restricted Stock Units | 100,000 | Direct |
| March 31, 2026 | HIVE | Restricted Stock Units | 100,000 | Direct |
| March 31, 2026 | HIVE | Restricted Stock Units | 100,000 | Direct |
| March 31, 2026 | HIVE | Restricted Stock Units | 100,000 | Direct |